2-Naphthalenesulphonyl L-Aspartyl-(2-Phenethyl)amide (2-Nap)-A Selective Cholecystokinin CCKA-receptor Antagonist

British Journal of Pharmacology - United States
doi 10.1111/j.1476-5381.1993.tb12870.x
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

Fevipiprant, a Selective Prostaglandin-D2 Receptor-2 Antagonist, Inhibits Human Group-2 Innate Lymphoid Cell Aggregation and Function

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Development of a Rat Parathyroid Hormone 2 Receptor Antagonist

Peptides
BiochemistryEndocrinologyPhysiologyCellularMolecular Neuroscience
2007English

Mechanism of Activation of a G Protein-Coupled Receptor, the Human Cholecystokinin-2 Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2007English

A Selective Orexin-1 Receptor Antagonist, SB334867, Blocks 2-Dg-Induced Gastric Acid Secretion in Rats

Neuroscience Letters
Neuroscience
2005English

Selective Cyclooxygenase-2 Inhibitor Ameliorates Cholecystokinin-Octapeptide-Induced Acute Pancreatitis in Rats

World Journal of Gastroenterology
MedicineGastroenterology
2007English

High Tumorigenic Potential of a Constitutively Active Mutant of the Cholecystokinin 2 Receptor

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Inhibition of Tumor Metastasis by a Growth Factor Receptor Bound Protein 2 SRC Homology 2 Domain-Binding Antagonist

Cancer Research
Cancer ResearchOncology
2007English

Ranitidine, a Histamine-2 Receptor Antagonist, Ameliorates Caerulein-Induced Pancreatitis in Rats

The Showa University Journal of Medical Sciences
2008English

Effects of a Newly Developed Potent Orexin-2 Receptor-Selective Antagonist, Compound 1 M, on Sleep/Wakefulness States in Mice

Frontiers in Neuroscience
Neuroscience
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy